Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis
Authors:
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 92 (8) , 1032-1039
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Medical Outcomes and Antimicrobial Costs With the Use of the American Thoracic Society Guidelines for Outpatients With Community-Acquired PneumoniaJAMA, 1997
- Clinical Utility of Blood Cultures in Adult Patients with Community-Acquired Pneumonia Without Defined Underlying RisksChest, 1995
- Identification of Low-Risk Hospitalized Patients With PneumoniaChest, 1994
- Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial TherapyAmerican Review of Respiratory Disease, 1993
- Parenteral Followed by Oral Ofloxacin for Nosocomial Pneumonia and Community-acquired Pneumonia Requiring HospitalizationAmerican Review of Respiratory Disease, 1992
- The value of routine microbial investigation in community-acquired pneumoniaRespiratory Medicine, 1991
- Cost-effective Use of AntibioticsArchives of internal medicine (1960), 1988
- Beta-Lactam AntibioticsNew England Journal of Medicine, 1988
- Cefamandole and CefoxitinAnnals of Internal Medicine, 1985
- Clinical Value of Paired Sputum and Transtracheal Aspirates in the Initial Management of Pneumonia*Chest, 1985